Maze Therapeutics, Inc. MAZE Q3 2025 earnings
Reported November 6, 2025 · Before market open
EPS estimate-$0.74
Next report
Aug 11, 2026 (In 4 weeks)Revenue estimate$2.9M
EPS estimate-$0.76
Financials
Q3 2025Valuation & ratios
Segments
By geography
Versus estimates
Revenue
Diluted EPS
Ask the moment Maze Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Maze Therapeutics, Inc. report Q3 2025 earnings?
- Maze Therapeutics, Inc. (MAZE) reported Q3 2025 earnings on November 6, 2025 before market open.
- What were Maze Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- Maze Therapeutics, Inc. reported diluted EPS of $-0.66 for Q3 2025.
- Did Maze Therapeutics, Inc. beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-0.74 by $0.08.
- How did Maze Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 16.7% from $-0.57.
- Where can I find Maze Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-269624) and the 10-Q periodic report (0001193125-25-269689) directly on SEC EDGAR. The filing index links above go to sec.gov.